Statistics for Abbott Laboratories (id:8486 ABT)
Valuation metrics
Market cap
201.02B
Enterprise value
208.51B
Trailing P/E (ttm)
35.23
Forward P/E
22.46
PEG ratio
22.46
Price/Sales (ttm)
4.88
Price/Book (mrq)
5.05
Enterprise Value/Revenue
5.06
Enterprise Value/EBITDA
19.26
Overview
Shares outstanding
1.73B
Float
1.72B
Shares short
14.07M
% Held by insiders
0.01%
% Held by institutions
0.77%
Average volume (10 days)
5.15M
Average volume (90 days)
Price summary
52-Week low
99.71
52-Week high
121.64
52-Week change
11.26%
Beta
0.72
50-Day moving average
115.53
200-Day moving average
110.72
Dividends and splits
Forward annual dividend rate
2.20
Forward annual dividend yield
0.02
Trailing annual dividend rate
2.20%
Trailing annual dividend yield
0.02
5-Year annual dividend yield
1.65
Payout ratio
0.66
Dividend date
November 15th, 2024
Ex-dividend date
October 15th, 2024
Last split factor
2:1
Last split date
January 02th, 2013
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
13.99%
Operating margin
18.75%
Operational effectiveness
Return on assets
6.49%
Return on equity
14.84%
Income statement
Revenue (ttm)
23.68
Revenue per share (ttm)
23.68
Quarterly revenue growth (yoy)
0.15
Gross profit (ttm)
22.13B
EBITDA
10.59B
Net income to common (ttm)
5.74B
Diluted EPS (ttm)
3.29
Quarterly earnings growth (yoy)
14.60%
Balance sheet
Total cash (mrq)
7.79B
Total cash per share (mrq)
4.49
Total debt (mrq)
15.05B
Total Debt/Equity (mrq)
37.59
Current ratio (mrq)
159.70%
Book value per share (mrq)
22.94
Cash flow
Cash flow statement
8.73B
Levered free cash flow (LFCF)
6.40B